MedTrace Logo

The Characterization of Blood Volumes of Commercially Available Lancing Devices

NCT01914302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2013-08-02

No results posted yet for this study

Summary

Characterize expressed blood volume ≥1μL across representative, commercially available lancing device systems using finger sticks.

Conditions

Interventions

DEVICE

Delica Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Flash Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Easy Touch Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Glucoject Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Microlet Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Multiclix Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Fastclix Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Reli-On Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

Sponsors & Collaborators

  • LifeScan

    collaborator INDUSTRY

  • Facet Technologies

    lead OTHER

Principal Investigators

  • Barry Ginsberg, MD

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01914302 on ClinicalTrials.gov